Frank Cools

Medicine · Health Sciences

22h-index6.7kcitations91works621.72yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Atrial Fibrillation Management and Outcomes(35), Cardiac electrophysiology and arrhythmias(17), Cardiac Arrhythmias and Treatments(17), Antiplatelet Therapy and Cardiovascular Diseases(16), Venous Thromboembolism Diagnosis and Management(15)

Publications88 total

Primary thromboprophylaxis in ambulatory symptomatic patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
Research and Practice in Thrombosis and Haemostasis·2024· 2 citedOpen Access
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
European Heart Journal·2024· 1.8k citedOpen Access
Clinical Outcomes in Older Patients with Atrial Fibrillation: Insights from the GARFIELD-AF Registry
The American Journal of Medicine·2023· 6 citedOpen Access
PB0049 Thromboprophylaxis with Enoxaparin for Symptomatic COVID-19 Managed in the Ambulatory Setting: Pooled Analysis of the OVID and ETHIC Trials
Research and Practice in Thrombosis and Haemostasis·2023Open Access
Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trials
Thrombosis Research·2023· 4 citedOpen Access
Determinants and clinical outcomes of patients who refused anticoagulation: findings from the global GARFIELD-AF registry
Open Heart·2023· 4 citedOpen Access
Heart of lymphoma: a case report
Acta cardiologica. Supplementum·2023· 1 cited
GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide
Clinical Research in Cardiology·2022· 12 citedOpen Access
Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial
The Lancet Haematology·2022· 60 citedOpen Access
Impact of NOAC and VKA on outcome of patients with newly diagnosed atrial fibrillation and diabetes: a report from the GARFIELD-AF registry
European Heart Journal·2021
CNS (EEG & behavior) safety assessment in freely moving/socially housed non-rodents
Journal of Pharmacological and Toxicological Methods·2021
Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD‐AF Registry
Journal of Thrombosis and Haemostasis·2021· 45 citedOpen Access
Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry
Blood Advances·2021· 60 citedOpen Access
Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and The Netherlands: insights from the ETNA-AF-Europe study
Acta cardiologica. Supplementum·2021· 2 citedOpen Access
Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and the Netherlands: insights from the ETNA-AF-Europe study
Netherlands Heart Journal·2021· 1 citedOpen Access
Permanent discontinuation of different anticoagulants in patients with atrial fibrillation and the impact on clinical outcome: data from the GARFIELD-AF registry
European Heart Journal·2020· 1 cited
Impact of different anticoagulation management strategies on outcomes in atrial fibrillation: Dutch and Belgian results from the GARFIELD‐AF registry
Journal of Thrombosis and Haemostasis·2020· 5 citedOpen Access
Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants
Journal of the American College of Cardiology·2020· 137 citedOpen Access
GARFIELD-AF: A Worldwide Prospective Registry of Patients With Atrial Fibrillation at Risk of Stroke
Future Cardiology·2020· 38 citedOpen Access
Echocardiographic and hemodynamic indices of myocardial contractility simultaneously evaluated in telemetered beagle dogs: A HESI-sponsored cross-company evaluation
Journal of Pharmacological and Toxicological Methods·2020· 1 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Ajay K. Kakkar(18), Sylvia Haas(17), Karen S. Pieper(17), Jean‐Pierre Bassand(15), Gloria Kayani(15), A. John Camm(14), Samuel Z. Goldhaber(12), Shinya Goto(12), Frank Misselwitz(12), Freek W.A. Verheugt(11), David Fitzmaurice(11), LG Mantovani(9), Saverio Virdone(9), Dan Atar(8), Keith A.A. Fox(8), Yukihiro Koretsune(8), Seil Oh(8), Stefan James(7), Lars Wallentin(7), Pantep Angchaisuksiri(7)